Live from the NIH registry
Studies recruiting near Santa Cruz right now
Top 25 of 163 recruiting studies, sorted by proximity — each links to its official registry page
A Study Evaluating the Efficacy and Safety of Inavolisib Plus CDK4/6 Inhibitor and Letrozole vs Placebo + CDK4/6i and Letrozole in Participants With Endocrine-Sensitive PIK3CA-Mutated, Hormone Receptor-Positive, HER2-Negative Advanced Breast Cancer
Breast Cancer
Phase 3
Interventional 450 participants sought
Palo Alto Medical Foundation Research Center — Sunnyvale, California (26.9 mi)
· Sponsor: Hoffmann-La Roche
Evaluation of Treatment Satisfaction and KarXT Utilization Registry (RESKU)
Schizophrenia
N/A
Observational 300 participants sought
Lumos Clinical Research Center — San Jose, California (26.1 mi)
· Sponsor: Bristol-Myers Squibb
Levonorgestrel 52 mg IUD for Emergency Contraception and Same-Day Start
Contraception
Phase 4
Interventional 1,404 participants sought
Planned Parenthood Mar Monte — San Jose, California (26.1 mi)
· Sponsor: University of Utah
A Study to Learn About How 20-Valent Pneumococcal Conjugate Vaccine Works in a Real-world Setting
Pneumonia
N/A
Observational 12,500 participants sought
Kaiser Permanente Santa Clara Medical Center — Santa Clara, California (26.3 mi)
· Sponsor: Pfizer
A Clinical Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) in People With Breast Cancer (MK-2870-032)
Breast Neoplasms, Triple Negative Breast Neoplasms
Phase 3
Interventional 2,400 participants sought
El Camino Hospital Cancer Center ( Site 0096) — Mountain View, California (28.3 mi)
· Sponsor: Merck Sharp & Dohme LLC
A Study to Evaluate the Efficacy of Pumitamig Versus Pembrolizumab in Participants With Previously Untreated Advanced Non-Small Cell Lung Cancer and PD-L1 ≥ 50%. (ROSETTA Lung-202)
Non-Small Cell Lung Cancer (NSCLC)
Phase 3
Interventional 750 participants sought
Pacific Cancer Care — Monterey, California (27.3 mi)
· Sponsor: Bristol-Myers Squibb
Transcatheter Mitral Valve Replacement With the Medtronic Intrepid™ TMVR System in Patients With Severe Symptomatic Mitral Regurgitation.
Mitral Valve Regurgitation
N/A
Interventional 1,056 participants sought
El Camino Hospital — Mountain View, California (28.3 mi)
· Sponsor: Medtronic Cardiovascular
Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25
Breast Cancer
Phase 3
Interventional 3,960 participants sought
Palo Alto Medical Foundation-Santa Cruz — Santa Cruz, California (0.4 mi)
· Sponsor: NRG Oncology
Surabgene Lomparvovec Administered in the Suprachoroidal Space in Adult Participants With Diabetic Retinopathy Without Center-Involved Diabetic Macular Edema
Diabetic Retinopathy
Phase 2, Phase 3
Interventional 576 participants sought
Northern California Retina Vitreous Associates /ID# 282994 — Mountain View, California (28.3 mi)
· Sponsor: AbbVie
Comparing the Outcome of Immunotherapy-Based Drug Combination Therapy With or Without Surgery to Remove the Kidney in Metastatic Kidney Cancer, the PROBE Trial
Metastatic Clear Cell Renal Cell Carcinoma, Metastatic Renal Cell Carcinoma
Phase 3
Interventional 364 participants sought
Palo Alto Medical Foundation-Santa Cruz — Santa Cruz, California (0.4 mi)
· Sponsor: SWOG Cancer Research Network
Testing the Addition of MEDI4736 (Durvalumab) to Chemotherapy Before Surgery for Patients With High-Grade Upper Urinary Tract Cancer
Renal Pelvis and Ureter Urothelial Carcinoma
Phase 2, Phase 3
Interventional 131 participants sought
Palo Alto Medical Foundation-Santa Cruz — Santa Cruz, California (0.4 mi)
· Sponsor: National Cancer Institute (NCI)
A Phase 2 Study of Zelquistinel or Placebo for the Reduction of Symptoms of Major Depressive Disorder
Major Depressive Disorder
Phase 2
Interventional 164 participants sought
Lumos Clinical Research Center — San Jose, California (26.1 mi)
· Sponsor: Syndeio Biosciences, Inc
A 52-week Study of Rilzabrutinib Efficacy and Safety Compared to Placebo in Adults Diagnosed With IgG4-related Disease
Immunoglobulin G4 Related Disease
Phase 3
Interventional 124 participants sought
San Jose Clinical Trials- Site Number : 8400016 — San Jose, California (26.1 mi)
· Sponsor: Sanofi
Follow-up Automatically vs. As-Needed Comparison (FAAN-C) Trial
Pneumonia, Urinary Tract Infections
N/A
Interventional 2,674 participants sought
Packard at El Camino Hospital — Mountain View, California (28.3 mi)
· Sponsor: University of Utah
A Primary Care Based Intervention to Prevent Childhood Obesity Among Low-income Latino Children
Obesity, Childhood
N/A
Interventional 576 participants sought
Valley Health Center Sunnyvale — Sunnyvale, California (26.9 mi)
· Sponsor: University of California, San Francisco
A Randomized, Double-Blind, Placebo-Controlled Trial on Efficacy and Safety of Fluticasone Propionate/Albuterol Sulfate Combination in Participants 12 Years and Older With Asthma
Asthma
Phase 3
Interventional 724 participants sought
Teva Investigational Site 12064 — San Jose, California (26.1 mi)
· Sponsor: Teva Branded Pharmaceutical Products R&D LLC
Motiva Implants® Post-Approval Study
Breast Implant
N/A
Interventional 2,400 participants sought
Los Gatos Plastic Surgery — Los Gatos, California (17.4 mi)
· Sponsor: Motiva USA LLC
TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer
Lymphoma, Non-Hodgkin, Multiple Myeloma
Phase 2
Interventional 4,200 participants sought
Sutter Palo Alto Medical Foundation: Santa Cruz — Santa Cruz, California (0.4 mi)
· Sponsor: American Society of Clinical Oncology
Telenutrition for Individuals With SCI
Spinal Cord Injuries, Obesity
N/A
Interventional 96 participants sought
Santa Clara Valley Medical Center — San Jose, California (26.1 mi)
· Sponsor: Santa Clara Valley Health & Hospital System
Testing New Therapies for Patients With Acute Myeloid Leukemia Who Are Newly Diagnosed and Have Not Yet Started Treatment (A MyeloMATCH Treatment Trial)
Acute Myeloid Leukemia, Acute Myeloid Leukemia Arising From Previous Myelodysplastic/Myeloproliferative Neoplasm
Phase 2
Interventional 335 participants sought
Kaiser Permanente Medical Center - Santa Clara — Santa Clara, California (26.3 mi)
· Sponsor: National Cancer Institute (NCI)
Testing the Role of DNA Released From Tumor Cells Into the Blood in Guiding the Use of Immunotherapy After Surgical Removal of the Bladder, Kidney, Ureter, and Urethra for Urothelial Cancer Treatment, MODERN Study
Muscle Invasive Bladder Urothelial Carcinoma, Muscle Invasive Renal Pelvis Urothelial Carcinoma
Phase 2, Phase 3
Interventional 992 participants sought
Kaiser Permanente-Santa Teresa-San Jose — San Jose, California (26.1 mi)
· Sponsor: National Cancer Institute (NCI)
SAFety and Efficacy of Human Anti-thymocyte ImmunoGlobUlin SAB-142 ARresting Progression of Type 1 Diabetes
Type 1 Diabetes
Phase 2
Interventional 159 participants sought
San Jose Clinical Trials, LLC — San Jose, California (26.1 mi)
· Sponsor: SAb Biotherapeutics, Inc.
Study to Assess Adverse Events and Disease Activity of Oral Ubrogepant Tablets for the Acute Treatment of Migraine in Children and Adolescents (Ages 6-17)
Migraine
Phase 3
Interventional 1,059 participants sought
Lumos Clinical Research Center /ID# 231267 — San Jose, California (26.1 mi)
· Sponsor: AbbVie
Docetaxel to Androgen Receptor Pathway Inhibitors in Patients With Metastatic Castration Sensitive Prostate Cancer and Suboptimal PSA Response
Prostate Cancer (Adenocarcinoma)
Phase 3
Interventional 830 participants sought
Stanford Cancer Center South Bay — San Jose, California (26.1 mi)
· Sponsor: Canadian Cancer Trials Group
Symbiotic-GI-03: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Metastatic Colorectal Cancer
Intestinal Neoplasms, Gastrointestinal Neoplasms
Phase 3
Interventional 800 participants sought
Palo Alto Medical Foundation - Sunnyvale Center — Sunnyvale, California (26.9 mi)
· Sponsor: Pfizer